Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology
about
Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model systemHLA-A2-restricted protection against lethal lymphocytic choriomeningitis.Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes.Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model.Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus.DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection.
P2860
Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Vaccination with a synthetic p ...... virus-mediated immunopathology
@ast
Vaccination with a synthetic p ...... virus-mediated immunopathology
@en
type
label
Vaccination with a synthetic p ...... virus-mediated immunopathology
@ast
Vaccination with a synthetic p ...... virus-mediated immunopathology
@en
prefLabel
Vaccination with a synthetic p ...... virus-mediated immunopathology
@ast
Vaccination with a synthetic p ...... virus-mediated immunopathology
@en
P2093
P2860
P1433
P1476
Vaccination with a synthetic p ...... virus-mediated immunopathology
@en
P2093
Battegay M
Hengartner H
Zinkernagel RM
P2860
P304
P407
P577
1992-02-01T00:00:00Z